| | Condition | Stage | ANOVA | T test |
|---|
| Norm baseline | Heat baseline | Heat–CO2 | Condition | Stage | Interaction |
|---|
| Tsk, °C | Air | 33.8 ± 0.7 | 39.0 ± 0.7 | 38.9 ± 1.0 | 0.959 | < 0.001 | 0.471 | 0.724 |
| CO2 | 33.9 ± 0.5 | 38.9 ± 1.0 |
| Tca, °C | Air | 37.2 ± 0.3 | 38.6 ± 0.2 | 38.7 ± 0.1 | 0.775 | < 0.001 | 0.365 | 0.060 |
| CO2 | 37.3 ± 0.1 | 38.6 ± 0.1 |
| HR, bpm | Air | 61.7 ± 7.1 | 104.3 ± 11.9 | 102.6 ± 8.7 | 0.083 | < 0.001 | 0.128 | 0.067 |
| CO2 | 60.4 ± 7.5 | 98.3 ± 7.4 |
| MAP, mmHg | Air | 76.4 ± 8.5 | 77.9 ± 8.9 | 86.3 ± 8.7 | 0.207 | 0.717 | 0.171 | 0.045 |
| CO2 | 85.1 ± 14.4 | 82.0 ± 9.1 |
| VE, L/min | Air | 7.1 ± 1.5 | 9.3 ± 2.8 | 17.0 ± 4.4 | 0.876 | 0.011 | 0.971 | 0.002 |
| CO2 | 7.3 ± 1.9 | 9.6 ± 2.0 |
| RR, n | Air | 14.7 ± 2.4 | 15.9 ± 5.0 | 18.1 ± 5.9 | 0.227 | 0.309 | 0.894 | 0.414 |
| CO2 | 14.1 ± 2.6 | 16.4 ± 3.4 |
| PETCO2, mmHg | Air | 42.9 ± 2.6 | 40.0 ± 5.4 | 49.3 ± 3.6 | 0.876 | 0.054 | 0.902 | 0.002 |
| CO2 | 43.0 ± 2.4 | 40.3 ± 4.0 |
| VA, mL/min | Air | 143.5 ± 43.8 | 141.8 ± 51.5 | 171.1 ± 51.7 | 0.045 | 0.439 | 0.619 | 0.010 |
| CO2 | 132.0 ± 41.2 | 123.0 ± 34.4 |
| ICA, mL/min | Air | 398.2 ± 72.9 | 352.2 ± 87.8 | 459.8 ± 100.5 | 0.586 | 0.039 | 0.645 | 0.019 |
| CO2 | 369.8 ± 70.8 | 337.9 ± 73.0 |
| %VA, %baseline | Air | 100 | 99.2 ± 18.7 | 133.0 ± 33.1 | 0.632 | 0.582 | 0.632 | 0.010 |
| CO2 | 100 | 94.7 ± 17.7 |
| %ICA, %baseline | Air | 100 | 88.7 ± 16.2 | 127.0 ± 35.7 | 0.685 | 0.040 | 0.685 | 0.040 |
| CO2 | 100 | 91.5 ± 9.5 |
- Blood flow values are depicted in absolute units and relative changes from the normothermic baseline prior to LBNP challenge. Values are mean ± SD were averaged from steady-state supine data at normothermic (Norm baseline) and during heat stress (Heat baseline). Prior to the LBNP challenge, the hypercapnic gas was applied in the CO2 trial (Heat CO2) only. Tsk, mean skin temperature; Tca, external canal temperature; VE, minute ventilation; RR, respiratory rate; PETCO2, partial pressure of end-tidal carbon dioxide; MAP, mean arterial blood pressure; HR, heart rate; ICA, internal carotid artery; VA, vertebral artery blood flow. ICA and VA blood flows were depicted in absolute units and relative changes (i.e., normalized relative to the respective normothermic baselines). Subjects performed two progressive lower body pressure during heat stress with (CO2 trial) or without (Air trial) an application of hypercapnic gas mixture on different day. Thermal, hemodynamic, respiratory, and cerebrovascular variables were evaluated by a two-way repeated measures analysis of variance (ANOVA). The paired T test (Heat baseline vs. Heat CO2) performed to evaluate the effect of inhaling hypercapnic gas on these variables